News

Strides‘ oncology facility was established in 2009 and it manufactures injectables, oral products (tablets and softgels) in the oncology domain. The approval will allow the company to widen

Fusilev is a folate analog, which is approved as a ready-to-use (Fusilev injection) solution in 175mg and 250mg vials, and as freeze-dried powder (Fusilev for injection) in 50mg

The new application manages the entire sales talent lifecycle from onboarding, to incentives and rewards, to coaching and performance optimization, while offering visibility into operations and financial performance.

AndroGel (testosterone gel) 1.62% is a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose

For the first quarter of 2011, the company reported a net income of $1.07bn, compared to $330m for the same period in 2010. Merck’s worldwide sales were $11.6bn

The trial is intended to establish if Multikine administered prior to current standard of care (surgery plus radiotherapy or surgery plus concurrent chemo radiotherapy) in previously untreated subjects

The company has posted a net income of $255.08m, compared to $234.44m for the same period in 2010. For the first quarter of 2011, Celgene‘s operating income was

IDT is the supplier of custom nucleic acids in the US, serving academic, government and commercial researchers in biotechnology, clinical diagnostics and pharmaceutical development. The novel proprietary probe

The Phase IIb trial was originally started in July 2009 and involves a two-year follow up on the infants vaccinated as part of the trial to investigate whether